Thu, January 3, 2013
Wed, January 2, 2013

Christopher Raymond Downgraded (BIIB) to Hold and Decreased Target to $166 on, Jan 3rd, 2013

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. and-decreased-target-to-166-on-jan-3rd-2013.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Christopher Raymond of Piper Sandler, Downgraded "Biogen Inc." (BIIB) to Hold and Decreased Target from $175 to $166 on, Jan 3rd, 2013.

Christopher has made no other calls on BIIB in the last 4 months.



There are 2 other peers that have a rating on BIIB. Out of the 2 peers that are also analyzing BIIB, 0 agree with Christopher's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Christopher


  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $175 on, Monday, October 8th, 2012
  • Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $160 on, Thursday, September 6th, 2012